PASG
Passage Bio, Inc.NASDAQHealthcare$8.76+8.42%ClosedMarket Cap: $28.1M
As of 2026-04-07
Analyst Consensus
Consensus
Buy
Target (Consensus)
$6.00
Target (Median)
$6.00
Target Range
$6.00 - $6.00
Upside from current price: -31.5%
Rating Distribution
0 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-04 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-11-12 | Chardan Capital | maintain | Buy | Buy |
| 2025-08-14 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-08-14 | Guggenheim | maintain | Buy | Buy |
| 2025-08-13 | Wedbush | maintain | Outperform | Outperform |
| 2025-06-24 | Chardan Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-5.58 | $45.0M | 4 |
| Sun Dec 31 | $-4.31 | $31.5M | 4 |
| Mon Dec 31 | $-4.32 | $15.0M | 2 |
| Tue Dec 31 | $-1.13 | $43.6M | 2 |